Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jayesh Desai

Showing results (11-20 of 179) with videos related to

Pageof 18
Sort By:
Asia-Pacific Journal of Clinical Oncology|February 29, 2012
Dose optimization of tyrosine kinase inhibitors to improve outcomes in GISTJohn R Zalcberg, Jayesh Desai
Pathology|January 1, 2014
An Australasian perspective on sarcoma research, translational biology and clinical trials: the Australasian Sarcoma Study Group (ASSG)Susie Bae, Denise Caruso, Jayesh Desai
Chinese Clinical Oncology|July 18, 2019
The value of networks in driving phase I trials: the Peter MacCallum Cancer Centre experienceJayesh Desai, Christina Guo, Ben Tran
Pharmacology & Therapeutics|May 30, 2025
Recent advances in therapeutic targeting of the KRAS pathway in cancerNadia Hitchen, Sarah Williams, Jayesh Desai
Annals of Surgical Oncology|April 13, 2018
Systematic Review of Clinical Outcomes Following Various Treatment Options for Patients with Extraabdominal Desmoid TumorsKortnye Smith, Jayesh Desai, Smaro Lazarakis, et al.
Current Oncology (Toronto, Ont.)|September 30, 2021
Activity of the Gamma Secretase Inhibitor AL101 in Desmoid Tumors: A Case Report of 2 Adult CasesDavid Chan, Jason Kaplan, Gary Gordon, et al.
Contemporary Clinical Trials Communications|January 11, 2024
Changing trends in phase 1 oncology clinical trialsRichard Kelly, Christina Guo, Jayesh Desai, et al.
Clinical Endocrinology|April 9, 2008
Thyrotoxicosis during sunitinib treatment for renal cell carcinomaMathis Grossmann, Erosha Premaratne, Jayesh Desai, et al.
Clinical & Translational Immunology|February 9, 2022
Therapeutic strategies to remodel immunologically cold tumorsMinyu Wang, Sen Wang, Jayesh Desai, et al.
Clinical Colorectal Cancer|May 30, 2024
BRAF<sup>V600E</sup>-Mutant Metastatic Colorectal Cancer: Current Evidence, Future Directions, and Research PrioritiesOliver Piercey, Jeanne Tie, Frederic Hollande, et al.
Pageof 18

Showing results (11-20 of 179) with videos related to

Sort By:
Pageof 18
Asia-Pacific Journal of Clinical Oncology|February 29, 2012
Dose optimization of tyrosine kinase inhibitors to improve outcomes in GISTJohn R Zalcberg, Jayesh Desai
Pathology|January 1, 2014
An Australasian perspective on sarcoma research, translational biology and clinical trials: the Australasian Sarcoma Study Group (ASSG)Susie Bae, Denise Caruso, Jayesh Desai
Chinese Clinical Oncology|July 18, 2019
The value of networks in driving phase I trials: the Peter MacCallum Cancer Centre experienceJayesh Desai, Christina Guo, Ben Tran
Pharmacology & Therapeutics|May 30, 2025
Recent advances in therapeutic targeting of the KRAS pathway in cancerNadia Hitchen, Sarah Williams, Jayesh Desai
Annals of Surgical Oncology|April 13, 2018
Systematic Review of Clinical Outcomes Following Various Treatment Options for Patients with Extraabdominal Desmoid TumorsKortnye Smith, Jayesh Desai, Smaro Lazarakis, et al.
Current Oncology (Toronto, Ont.)|September 30, 2021
Activity of the Gamma Secretase Inhibitor AL101 in Desmoid Tumors: A Case Report of 2 Adult CasesDavid Chan, Jason Kaplan, Gary Gordon, et al.
Contemporary Clinical Trials Communications|January 11, 2024
Changing trends in phase 1 oncology clinical trialsRichard Kelly, Christina Guo, Jayesh Desai, et al.
Clinical Endocrinology|April 9, 2008
Thyrotoxicosis during sunitinib treatment for renal cell carcinomaMathis Grossmann, Erosha Premaratne, Jayesh Desai, et al.
Clinical & Translational Immunology|February 9, 2022
Therapeutic strategies to remodel immunologically cold tumorsMinyu Wang, Sen Wang, Jayesh Desai, et al.
Clinical Colorectal Cancer|May 30, 2024
BRAF<sup>V600E</sup>-Mutant Metastatic Colorectal Cancer: Current Evidence, Future Directions, and Research PrioritiesOliver Piercey, Jeanne Tie, Frederic Hollande, et al.
Pageof 18